Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Bell

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Immunity|April 16, 1999
TCR binding to peptide-MHC stabilizes a flexible recognition interfaceB E Willcox, G F Gao, J R Wyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascadeM A Purbhoo, A K Sewell, P Klenerman, et al.
European Journal of Immunology|February 17, 2001
Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion moleculesS Tafuro, U C Meier, P R Dunbar, et al.
European Journal of Immunology|April 12, 2001
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus loadA Oxenius, H F Günthard, B Hirschel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chainM P Davenport, C L Quinn, R M Chicz, et al.
Nature Genetics|October 1, 1996
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12J Satsangi, M Parkes, E Louis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Science (New York, N.Y.)|May 20, 1988
A molecular basis for MHC class II--associated autoimmunityJ A Todd, H Acha-Orbea, J I Bell, et al.
Lancet (London, England)|August 28, 1993
CD44 and cancer screeningS B Fox, K C Gatter, D G Jackson, et al.
Science (New York, N.Y.)|October 4, 1996
Phenotypic analysis of antigen-specific T lymphocytesJ D Altman, P A Moss, P J Goulder, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Immunity|April 16, 1999
TCR binding to peptide-MHC stabilizes a flexible recognition interfaceB E Willcox, G F Gao, J R Wyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascadeM A Purbhoo, A K Sewell, P Klenerman, et al.
European Journal of Immunology|February 17, 2001
Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion moleculesS Tafuro, U C Meier, P R Dunbar, et al.
European Journal of Immunology|April 12, 2001
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus loadA Oxenius, H F Günthard, B Hirschel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chainM P Davenport, C L Quinn, R M Chicz, et al.
Nature Genetics|October 1, 1996
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12J Satsangi, M Parkes, E Louis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Science (New York, N.Y.)|May 20, 1988
A molecular basis for MHC class II--associated autoimmunityJ A Todd, H Acha-Orbea, J I Bell, et al.
Lancet (London, England)|August 28, 1993
CD44 and cancer screeningS B Fox, K C Gatter, D G Jackson, et al.
Science (New York, N.Y.)|October 4, 1996
Phenotypic analysis of antigen-specific T lymphocytesJ D Altman, P A Moss, P J Goulder, et al.
Pageof 15